Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 2/20 | 0.50 |
| ▸ | CTSK | P43235 | 2/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | TACR3 | P29371 | 2/20 | 0.40 |
| ▸ | GPR88 | Q9GZN0 | 3/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1554126 | 0.94 | CTSS (0.48) | CTSSCTSKS1PR3MIFESR1 | |
| SCHEMBL2582580 | 0.94 | CTSS (0.48) | CTSSCTSKS1PR3MIFESR1 | |
| SCHEMBL1554122 | 0.94 | CTSS (0.48) | CTSSCTSKS1PR3MIFESR1 | |
| SCHEMBL15258988 | 0.90 | CTSS (0.48) | CTSSCTSKS1PR3MIFESR1 | |
| SCHEMBL17137904 | 0.88 | CTSS (0.64) | CTSSCTSKS1PR3GPR88SCN9A | |
| SCHEMBL11355325 | 0.88 | CTSS (0.54) | CTSSCTSKS1PR3MIFGPR88 | |
| SCHEMBL17137905 | 0.88 | CTSS (0.64) | CTSSCTSKS1PR3GPR88SCN9A | |
| SCHEMBL17137903 | 0.88 | CTSS (0.64) | CTSSCTSKS1PR3GPR88SCN9A | |
| SCHEMBL15962588 | 0.87 | CTSS (0.49) | CTSSCTSKS1PR3MIFESR1 | |
| Water SCHEMBL11354352 | 0.86 | CTSS (0.56) | CTSSCTSKS1PR3MIFGPR88 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242491-A1 | DIMERS FROM BIOREACHABLE MOLECULES AS COPOLYMERS | ZYMERGEN INC. (US) | 2023-08-03 | — | — | US | disclosed |
| US-20230242491-A1 | DIMERS FROM BIOREACHABLE MOLECULES AS COPOLYMERS | ZYMERGEN INC. (US) | 2023-08-03 | — | — | US | disclosed |
| US-20230242720-A1 | MODULUS MODIFIERS AND FILMS THEREOF | ZYMERGEN ACQUISITION SUB, INC. | 2023-08-03 | — | — | US | disclosed |
| US-20230242720-A1 | MODULUS MODIFIERS AND FILMS THEREOF | ZYMERGEN ACQUISITION SUB, INC. | 2023-08-03 | — | — | US | disclosed |
| WO-2022006023-A1 | DIMERS FROM BIOREACHABLE MOLECULES AS COPOLYMERS | ZYMERGEN INC. (US) | 2022-01-06 | — | — | WO | disclosed |
| WO-2022006145-A1 | MODULUS MODIFIERS AND FILMS THEREOF | ZYMERGEN INC. (US) | 2022-01-06 | — | — | WO | disclosed |
| WO-2020142450-A1 | POLYMER COMPOSITIONS COMPRISING COMPOUNDS DERIVED FROM BIOLOGY | ZYMERGEN INC. (US) | 2020-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242491-A1 | DIMERS FROM BIOREACHABLE MOLECULES AS COPOLYMERS | HDHD5, HAO2, ALAD | CTSS 2969/4885CTSK 3611/4885S1PR3 4852/4885 |
| US-20230242720-A1 | MODULUS MODIFIERS AND FILMS THEREOF | SHBG, PTMS, SERPINA6 | CTSS 4283/4885CTSK 3923/4885S1PR3 4522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.